Compound Profile

Apigenin

Decision ready summary: Apigenin is best framed for relaxation; sleep support; mild anxiety context; safety screen: sedatives; anticoagulants caution; pregnancy safety uncertainty.

Last reviewed:

D Traditional

Monograph visual

Apigenin

Generated profile category visual

Verdict: ApigeninMaybe

Best for

  • Mild pre-sleep calm
  • Exploring chamomile’s active flavonoid
  • A gentle stack ingredient

Not ideal for

  • Significant insomnia or anxiety
  • Anyone expecting real sedation
Evidence confidence
Preliminary — mostly preclinical, little human data on isolated apigenin
Expected onset
~1 hour
Give it
1–2 weeks
Bottom line: Apigenin is the flavonoid behind chamomile’s calming reputation, but most evidence is preclinical — as an isolated supplement it is a gentle experiment, not a proven sleep aid.

On the evidence: Largely preclinical; human data on isolated apigenin is sparse.

Consider instead: Magnesiumfor a better-evidenced, low-risk sleep base

How strong is the evidence?Preliminary

Why not higher

  • Most evidence is animal/cell, not human
  • Little data on isolated apigenin as a supplement

Why not lower

  • A plausible mechanism and the long track record of chamomile
  • Low risk at culinary/supplemental amounts

Practical takeaway: A low-stakes option for mild pre-sleep calm. For better-evidenced help, magnesium or L-theanine are stronger starting points.

Where to go next — guides & comparisons

Start here — new to this? Begin with Natural sleep aids that work

Continue reading

Quick Stats

Evidence level

Preliminary evidence

Typical onset

Varies by prep

Safety rating

Use extra caution: Interaction risk

Best for

GABAergic Signaling, NF κB, Nrf2

Avoid / review if

Pregnancy

Safety & Cautions

Review before use if any apply: Pregnancy.

Evidence Summary

D Traditional

Evidence lens

Read as directional context, not settled clinical proof.

LimitedPreliminary evidence

Human clinical evidence: Not the primary signal

Mechanistic / preclinical: Mechanism mappedInflammatory Signaling Modulation · Oxidative Stress Modulation · Mitochondrial Support

Research maturity: More interpretablemain contexts: GABAergic Signaling · NF κB · Nrf2

Safety boundary: Safety note availableReview before use if any apply: Pregnancy.

Evidence Strength

Confidence estimate based on the design quality and consistency of published clinical trials.

Preliminary evidence

Apigenin has a preliminary evidence evidence rating.

AdaptogenSleepStress & MoodLongevity
Effects
5
How evidence grades work

Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.

A

Strong

Multiple RCTs, consistent direction, adequate effect size

B

Moderate

Some RCTs or consistent observational data in humans

C

Preliminary / Mixed

Animal or in-vitro only, or conflicting human data

D

Traditional / Theoretical

Traditional use only; no controlled human trials

How Apigenin Works

Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.

Mechanism Pathway — How Apigenin Works

How Apigenin WorksApigenin acts on pathways via anti inflammatory, leading to gabaergic signaling.ApigeninBiological pathwayAnti InflammatoryGabaergic SignalingObservable outcomeAntioxidantParallel pathway
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & Biological Pathways

Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.

Inflammatory Signaling ModulationOxidative Stress ModulationMitochondrial SupportNeurotransmitter ModulationStress Response ModulationNeuroprotective Activity

Condition guides

Continue exploring

Related research paths

Compare & Sourcing

Compare side-by-side tradeoffs or verify active marker guidelines.

Review available sources for Apigenin

Independent database mapping — evaluated separately from safety and efficacy scores.

Check sourcing options

Affiliate Disclosure: Shopping links may earn this site a commission at no cost to you. Links are chosen on quality and availability, never commission tiers; safety warnings and evidence ratings stay independent.

Free safety checklist

Get the Apigenin evidence notes

Occasional research updates, safety context, and product-quality checks for supplement decisions.

We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.

Safety first · Harm reduction

This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.

Learn how we evaluate confidence, safety, and intensity on the methodology page.

Editorial Review

Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.

Editorial Standards →

Compound profile context

How to interpret Apigenin

Apigenin dosage by use case, onset and duration, safety limits, and interactions for gabaergic signaling, graded against research. Mechanistic Evidence… Use this compound profile to understand mechanism, evidence quality, and practical safety context before comparing products or building a stack. A biochemical pathway connection can be useful for discovery, but it is not the same as proven benefit in humans.

When reviewing Apigenin, separate the active molecule from the product category around it. Dose form, absorption, extract standardization, medication interactions, and individual sensitivity can change the real-world risk-benefit picture.

For supplement planning, avoid combining multiple compounds with overlapping sedating, stimulating, serotonergic, blood-pressure, anticoagulant, or liver-metabolism effects unless a qualified clinician has reviewed the context.